Prasugrel Or Ticagrelor De-escalation in NSTE-ACS

NCT05779059 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Non ST Segment Elevation Acute Coronary Syndrome
Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)
Unstable Angina

Interventions

DRUG: De-escalation to ticagrelor 60 mg at day 30
DRUG: De-escalation to prasugrel 5 mg at day 30
DRUG: Switch to ticagrelor 60 mg at day 45
DRUG: Switch to prasugrel 5 mg at day 45

Sponsor

Collegium Medicum w Bydgoszczy